SPI1 and metabolic disease: Recently, the transcription factor pu.1 has been recognized as a pivotal regulator in metabolic disorders (Lackey et al., 2019; Liu et al., 2020; Pimenova et al., 2021), prompting investigations into its potential role in governing lipid metabolism alterations after SCI.